BioCentury
ARTICLE | Clinical News

Raptiva efalizumab regulatory update

June 28, 2004 7:00 AM UTC

EMEA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Raptiva to treat moderate to severe chronic plaque psoriasis. Serono S.A. (SWX:SEO, SRA, Geneva, Switzerlan...